1- (4- fluorobenzoyl)- 3- (((6- methoxy- 2- naphthyl)oxy)methyl)azetidine- 3- carboxylic acid
structure in first source
Also Known As:
PF-04418948
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Colorectal Neoplasms (Colorectal Cancer)
|
2. | Hypoxia (Hypoxemia)
01/01/2023
- " The effect of hypoxia on the diameter of larger arterioles, precapillary arterioles and capillaries was studied in the presence of the ecto-nucleotidase inhibitor AOPCP, the nonselective P2 purinoreceptor antagonist PPADS, the A2B adenosine receptor antagonist MRS 1754, the A3 adenosine receptor antagonist MRS 1523, the EP1 receptor antagonist SC-19220, the EP2 receptor antagonist PF-04418948, the EP3 receptor antagonist L-798,106, the EP4 receptor antagonist L-161-982, the prostaglandin synthesis inhibitor ibuprofen, and ibuprofen combined with AOPCP or ATP. "
|
|
Related Drugs and Biologics
1. | Purinergic P1 Receptor Antagonists
|
2. | 2-acetylhydrazide 8-chloro- Dibenz(b,f)(1,4)oxazepine- 10(11H)- carboxylic acid
|
3. | Prostaglandins
|
4. | Ibuprofen (Motrin)
|
5. | Adenosine Triphosphate (ATP)
|
6. | alpha,beta-methyleneadenosine 5'-diphosphate
|
7. | N- (4- cyanophenyl)- 2- (4- (2,3,6,7- tetrahydro- 2,6- dioxo- 1,3- dipropyl- 1H- purin- 8- yl)- phenoxy)acetamide
|
8. | 2,3- diethyl- 4,5- dipropyl- 6- phenylpyridine- 3- thiocarboxylate- 5- carboxylate
|
9. | pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid
|
10. | ectoATPase
|
|